Medical specialists from Serbia tagged as investigators in clinical trials studying Stomach Cancer

Total 6 results

Davorin Radosavljevic, MD
Seen in:
- Belgrade, Institute for Oncology and Radiology of Serbia - PPDS
Trials:
- NCT05152147 (Principal Investigator)
Conditions:
Ivan Nikolic, MD
Seen in:
- Sremska Kamenica, Oncology Institute of Vojvodina
Trials:
- NCT05152147 (Principal Investigator)
Conditions:
Miljana Dzunic
Seen in:
- Niš, University Clinical Center Nis
Trials:
- NCT05152147 (Principal Investigator)
Conditions:
Nenad Mijalkovic, MD
Seen in:
- Belgrade, University Clinical Center of Serbia - PPDS
Trials:
- NCT05152147 (Principal Investigator)
Conditions:
Zoran Andric, MD
Seen in:
- Belgrade, Clinical Hospital Center Bezanijska Kosa
- Belgrade, University Hospital Medical Center (KBC) Bezanijska Kosa
Trials:
- NCT05152147 (Principal Investigator)
- NCT04538625 (Principal Investigator)
- NCT04622007 (Principal Investigator)
Conditions:
Zoran Petrovic, MD
Seen in:
- Belgrade, Military Medical Academy
Trials:
- NCT05152147 (Principal Investigator)
Conditions:

Clinical Trials on Stomach Cancer

Jeeyun Lee

Recruiting

Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

Stomach Cancer, Adenocarcinoma

Korea, Republic of
Chinese University of Hong Kong

Unknown

Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial

Cancer of Stomach

China
Chinese University of Hong Kong

Unknown

Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial

Cancer of Stomach

China
Ohio State University Comprehensive Cancer Center
Pharmacia and Upjohn

Completed

Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

Stomach Cancer | Esophageal Cancer | Cancer of Stomach | Esophagus Cancer

United States
Bayer

Completed

EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK (ENgAGE-UK)

Prevention of Oesophagus Cancer and Stomach Cancer

United Kingdom
Chinese University of Hong Kong

Recruiting

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

Cancer of Stomach, Adenocarcinoma

Hong Kong
Dana-Farber Cancer Institute
Massachusetts General Hospital; Genentech, Inc.; SCRI Development Innovations... and other collaborators

Completed

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Stomach Cancer | Gastric Cancer | Esophageal Cancer

United States
Xijing Hospital of Digestive Diseases

Completed

Comparison of O-type Hybrid Knife and IT Knife in ESD

Stomach Cancer | Esophageal Cancer | Esophageal Dysplasia | Stomach Dysplasia

China
MacroGenics
Merck Sharp & Dohme LLC

Completed

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Stomach Cancer | Gastric Cancer | Esophageal Cancer

Korea, Republic of, United States, Taiwan, Singapore, Canada
Dana-Farber Cancer Institute
Massachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital

Completed

Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Stomach Cancer | Esophageal Cancer

United States

Medical specialists from Serbia tagged as investigators in clinical trials studying Stomach Cancer

Clinical Trials on Stomach Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations